Drug Trials Snapshot: BYLVAY (odevixibat)

Drug Trials Snapshot: BYLVAY (odevixibat) BYLVAY is a drug used to treat pruritus (itching) due to progressive familial intrahepatic cholestasis (PFIC) in patients 3 months of age or older. PFIC is a rare condition where bile acid, which is produced in the liver to help digest dietary fats and oils, is unable to be secreted out of liver leading to liver injury (cholestatic liver injury). https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshot-bylvay